Search Results - "Lancet neurology"
-
1
Neurological associations of COVID-19
Published in Lancet neurology (01-09-2020)“…The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is of a scale not seen since the 1918 influenza pandemic…”
Get full text
Journal Article -
2
Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria
Published in Lancet neurology (01-03-2023)“…Serum antibodies directed against myelin oligodendrocyte glycoprotein (MOG) are found in patients with acquired CNS demyelinating syndromes that are distinct…”
Get full text
Journal Article -
3
Challenges in the diagnosis of Parkinson's disease
Published in Lancet neurology (01-05-2021)“…Parkinson's disease is the second most common neurodegenerative disease and its prevalence has been projected to double over the next 30 years. An accurate…”
Get full text
Journal Article -
4
Traumatic brain injury: progress and challenges in prevention, clinical care, and research
Published in Lancet neurology (01-11-2022)“…InTBIR studies have shown that measurement of blood-based biomarkers adds value to previously proposed clinical decision rules, holding the potential to…”
Get full text
Journal Article -
5
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts
Published in Lancet neurology (01-05-2020)“…CSF and PET biomarkers of amyloid β and tau accurately detect Alzheimer's disease pathology, but the invasiveness, high cost, and poor availability of these…”
Get full text
Journal Article -
6
The characterisation of subjective cognitive decline
Published in Lancet neurology (01-03-2020)“…A growing awareness about brain health and Alzheimer's disease in the general population is leading to an increasing number of cognitively unimpaired…”
Get full text
Journal Article -
7
Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group
Published in Lancet neurology (01-06-2021)“…In 2018, the US National Institute on Aging and the Alzheimer's Association proposed a purely biological definition of Alzheimer's disease that relies on…”
Get full text
Journal Article -
8
Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
Published in Lancet neurology (01-10-2021)“…Regularly updated data on stroke and its pathological types, including data on their incidence, prevalence, mortality, disability, risk factors, and…”
Get full text
Journal Article -
9
Small vessel disease: mechanisms and clinical implications
Published in Lancet neurology (01-07-2019)“…Small vessel disease is a disorder of cerebral microvessels that causes white matter hyperintensities and several other common abnormalities (eg, recent small…”
Get full text
Journal Article -
10
APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approaches
Published in Lancet neurology (01-01-2021)“…The APOE ε4 allele remains the strongest genetic risk factor for sporadic Alzheimer's disease and the APOE ε2 allele the strongest genetic protective factor…”
Get full text
Journal Article -
11
Dementia in China: epidemiology, clinical management, and research advances
Published in Lancet neurology (01-01-2020)“…China has the largest population of patients with dementia in the world, imposing a heavy burden on the public and health care systems. More than 100…”
Get full text
Journal Article -
12
The global burden of neurological disorders: translating evidence into policy
Published in Lancet neurology (01-03-2020)“…Neurological disorders are the leading cause of disability and the second leading cause of death worldwide. In the past 30 years, the absolute numbers of…”
Get full text
Journal Article -
13
Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study
Published in Lancet neurology (01-03-2022)“…Serum neurofilament light chain (sNfL) is a biomarker of neuronal damage that is used not only to monitor disease activity and response to drugs and to…”
Get full text
Journal Article -
14
2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis
Published in Lancet neurology (01-08-2021)“…The 2015 Magnetic Resonance Imaging in Multiple Sclerosis and 2016 Consortium of Multiple Sclerosis Centres guidelines on the use of MRI in diagnosis and…”
Get full text
Journal Article -
15
Global brain inflammation in stroke
Published in Lancet neurology (01-11-2019)“…Stroke, including acute ischaemic stroke and intracerebral haemorrhage, results in neuronal cell death and the release of factors such as damage-associated…”
Get full text
Journal Article -
16
Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
Published in Lancet neurology (01-04-2024)“…Disorders affecting the nervous system are diverse and include neurodevelopmental disorders, late-life neurodegeneration, and newly emergent conditions, such…”
Get full text
Journal Article -
17
Neuroimaging standards for research into small vessel disease—advances since 2013
Published in Lancet neurology (01-07-2023)“…Cerebral small vessel disease (SVD) is common during ageing and can present as stroke, cognitive decline, neurobehavioural symptoms, or functional impairment…”
Get full text
Journal Article -
18
An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models
Published in Lancet neurology (01-11-2019)“…The identification of anti-NMDA receptor (NMDAR) encephalitis about 12 years ago made it possible to recognise that some patients with rapidly progressive…”
Get full text
Journal Article -
19
Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study
Published in Lancet neurology (01-05-2023)“…Emerging evidence shows that α-synuclein seed amplification assays (SAAs) have the potential to differentiate people with Parkinson's disease from healthy…”
Get full text
Journal Article -
20
Global, regional, and national burden of epilepsy, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
Published in Lancet neurology (01-04-2019)“…Seizures and their consequences contribute to the burden of epilepsy because they can cause health loss (premature mortality and residual disability). Data on…”
Get full text
Journal Article